Dianthus Therapeutics (DNTH) Preferred Dividend Payments (2017 - 2018)
Dianthus Therapeutics (DNTH) posted quarterly Preferred Dividend Payments of $88000.0 for Q2 2018, down 57.49% year-over-year from $207000.0 in Q2 2017, and up 1366.67% quarter-over-quarter from $6000.0 in Q3 2017.
Dianthus Therapeutics (DNTH) Preferred Dividend Payments (2017 - 2018) Analysis & Trends
Dianthus Therapeutics' Preferred Dividend Payments history runs 2 years deep, the most recent figure standing at $88000.0 for Q2 2018.
- In Q2 2018, Preferred Dividend Payments fell 57.49% year-over-year to $88000.0; the TTM figure through Dec 2018 stood at $88000.0 (changed N/A YoY), while the FY2018 annual figure was $88000.0, down 79.86% from the prior year.
- Preferred Dividend Payments for Q2 2018 stood at $88000.0, up from $6000.0 in the prior quarter.
- The five-year high for Preferred Dividend Payments was $207000.0 in Q2 2017, with the low at $6000.0 in Q3 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Dianthus Therapeutics | 4.97 Bn | 4.57 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2018 | 88,000.00 |
| Sep 30, 2017 | 6,000.00 |
| Jun 30, 2017 | 207,000.00 |